FLOT2 and open-angle glaucoma: Thus, FLOT2, which is associated with the prognosis of a variety of diseases, may fail to serve as an independent POAG biomarker, although it has the potential to be an indicator for disease screening, progression, recurrence, and treatment efficacy.